Fem recerca per la salut de les persones

0
0
0
s2smodern

Consulta els darrers articles científics de l'IDIAPJGol

En aquest llistat trobaràs les publicacions més recents en revistes científiques de l'IDIAPJGol o amb la col·laboració dels nostres investigadors i investigadores.

foto publicacions cientifiques IDIAPJGol 682x376

Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study.

Tomic D, Morton JI, Chen L, Salim A, Gregg EW, Pavkov ME, Arffman M, Balicer R, Baviera M, Boersma-van Dam E, Brinks R, Carstensen B, Chan JCN, Cheng YJ, Fosse-Edorh S, Fuentes S, Gardiner H, Gulseth HL, Gurevicius R, Ha KH, Hoyer A, Jermendy G, Kautzky-Willer A, Keskimäki I, Kim DJ, Kiss Z, Klimek P, Leventer-Roberts M, Lin CY, Lopez-Doriga Ruiz P, Luk AOY, Ma S, Mata-Cases M, Mauricio D, McGurnaghan S, Imamura T, Paul SK, Peeters A, Pildava S, Porath A, Robitaille C, Roncaglioni MC, Sugiyama T, Wang KL, Wild SH, Yekutiel N, Shaw JE, Magliano DJ.Lancet Diabetes Endocrinol. 2022 Sep 29:S2213-8587(22)00252-2. doi: 10.1016/S2213-8587(22)00252-2. Online ahead of print.PMID: 36183736
Type 2 Diabetes Mellitus and COVID-19: A Narrative Review.
Rey-Reñones C, Martinez-Torres S, Martín-Luján FM, Pericas C, Redondo A, Vilaplana-Carnerero C, Dominguez A, Grau M.Biomedicines. 2022 Aug 26;10(9):2089. doi: 10.3390/biomedicines10092089.PMID: 36140191 Free PMC article. Review.
 
Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries.
Li X, Bilcke J, van der Velden AW, Bruyndonckx R, Coenen S, Bongard E, de Paor M, Chlabicz S, Godycki-Cwirko M, Francis N, Aabenhus R, Bucher HC, Colliers A, De Sutter A, Garcia-Sangenis A, Glinz D, Harbin NJ, Kosiek K, Lindbæk M, Lionis C, Llor C, Mikó-Pauer R, Radzeviciene Jurgute R, Seifert B, Sundvall PD, Touboul Lundgren P, Tsakountakis N, Verheij TJ, Goossens H, Butler CC, Beutels P; ALIC4Etrial investigators.Eur J Health Econ. 2022 Sep 22. doi: 10.1007/s10198-022-01521-2. Online ahead of print.PMID: 36131214
 
 
Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.
Violán C, Torán-Monserrat P, Quirant B, Lamonja-Vicente N, Carrasco-Ribelles LA, Chacón C, Manresa-Dominguez JM, Ramos-Roure F, Dacosta-Aguayo R, Palacios-Fernández C, Roso-Llorach A, Pujol A, Ouchi D, Monteagudo M, Montero-Alia P, Garcia-Sierra R, Arméstar F, Doladé M, Prat N, Bonet JM, Clotet B, Blanco I, Boigues-Pons M, Moreno-Millán N, Prado JG, Cáceres EMM; ProHEpiC-19 study.BMC Infect Dis. 2022 Sep 3;22(1):721. doi: 10.1186/s12879-022-07696-6.PMID: 36057544 Free PMC article.
 
 
Higher Arm Versus Lower Arm Systolic Blood Pressure and Cardiovascular Outcomes: a Meta-Analysis of Individual Participant Data From the INTERPRESS-IPD Collaboration.
Clark CE, Warren FC, Boddy K, McDonagh STJ, Moore SF, Teresa Alzamora M, Ramos Blanes R, Chuang SY, Criqui MH, Dahl M, Engström G, Erbel R, Espeland M, Ferrucci L, Guerchet M, Hattersley A, Lahoz C, McClelland RL, McDermott MM, Price J, Stoffers HE, Wang JG, Westerink J, White J, Cloutier L, Taylor RS, Shore AC, McManus RJ, Aboyans V, Campbell JL.Hypertension. 2022 Oct;79(10):2328-2335. doi: 10.1161/HYPERTENSIONAHA.121.18921. Epub 2022 Aug 2.PMID: 35916147 Free PMC article.
 
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysis.
Yang C, Williams RD, Swerdel JN, Almeida JR, Brouwer ES, Burn E, Carmona L, Chatzidionysiou K, Duarte-Salles T, Fakhouri W, Hottgenroth A, Jani M, Kolde R, Kors JA, Kullamaa L, Lane J, Marinier K, Michel A, Stewart HM, Prats-Uribe A, Reisberg S, Sena AG, Torre CO, Verhamme K, Vizcaya D, Weaver J, Ryan P, Prieto-Alhambra D, Rijnbeek PR.Semin Arthritis Rheum. 2022 Oct;56:152050. doi: 10.1016/j.semarthrit.2022.152050. Epub 2022 Jun 15.PMID: 35728447 Free article.